PD-1/L1 immune checkpoint inhibitors for KRAS-mutant non-small cell lung cancer: a multicenter retrospective real-world study. Wei K, Sun T, Feng X, Chen Y, et al. BMC Cancer 2025;25:444.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wei K, Sun T, Feng X, Chen Y, et al. PD-1/L1 immune checkpoint inhibitors for KRAS-mutant non-small cell lung cancer: a multicenter retrospective real-world study. BMC Cancer 2025;25:444.
PMID: 40075326